Programmed Death-Ligand 1 Immunoexpression in Triple Negative Breast Carcinoma in South Indian Women: A Cross-sectional Study at a Tertiary Care Centre

Introduction: Triple Negative Breast Cancer (TNBC) comprises 10-20% of all breast cancer cases and is characterised by a lack of differentiation, subpar response to therapy and a low survival rate. Programmed Death-Ligand 1 (PD-L1) is a type 1 transmembrane protein present in cancer cells. The inter...

ver descrição completa

Detalhes bibliográficos

Principais autores:	D Darshitha, Padma Priya Kasukurti, Clement Wilfred Devadass
Formato:	Artigo
Idioma:	Inglês
Publicado em:	JCDR Research and Publications Private Limited 2025-10-01
coleção:	Journal of Clinical and Diagnostic Research
Assuntos:	immune expression immunohistochemistry triple negative breast cancer
Acesso em linha:	https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&volume=19&issue=10&page=EC01&issn=0973-709x&id=21557
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!